Net income per share Celgene 2014-2018, by year
In 2018, Celgene's net income per basic share stood at 5.65 U.S. dollars. Celgene is a U.S.-based biotech company headquartered in Summit, New Jersey.
Net income per share for Celgene from 2014 to 2018 (in U.S. dollars)*
Loading statistic...
Basic Account
Get to know the platform
You only have access to basic statistics.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$69 USD $49 USD / Month *
in the first 12 months
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you
Overview
7
- Premium Statistic Pharmaceutical market: worldwide revenue 2001-2022
- Premium Statistic World pharmaceutical sales 2020-2022 by region
- Premium Statistic World pharmaceutical market distribution by submarket 2014-2022
- Premium Statistic Revenues of top 10 global pharmaceutical markets 2021
- Basic Statistic Top pharmaceutical products by sales worldwide 2022
- Premium Statistic Share of pharmaceutical value worldwide 2021, by country
- Premium Statistic Value share of pharmaceutical subsectors worldwide 2003 vs. 2021
Segments
8
- Premium Statistic Top therapy classes by spending global market 2027 forecast
- Premium Statistic Global pharmaceutical revenue by technology 2012-2026
- Basic Statistic Worldwide Rx drug sales excluding generics and orphan drugs 2012-2026
- Basic Statistic Projection of global revenue for orphan prescription drugs 2012-2026
- Basic Statistic Worldwide generic prescription drug sales 2012-2026
- Premium Statistic Revenue of the OTC pharmaceuticals industry worldwide 2016-2027
- Premium Statistic Global oncology spending 2011-2024
- Premium Statistic Tota pharmaceutical value worldwide 2021, by subsector
Companies
8
- Premium Statistic Top 50 pharmaceutical companies - Rx sales and R&D spending 2021
- Basic Statistic Global Rx drug market share by top companies 2019 and 2026
- Premium Statistic Top 10 biotech and pharmaceutical companies based on market cap 2022
- Premium Statistic Pfizer's total revenue 2006-2022
- Premium Statistic Novartis' revenue 2007-2022
- Premium Statistic Roche Group's total sales 2006-2022
- Premium Statistic Johnson & Johnson's total sales 2005-2022
- Basic Statistic Projected top pharmaceutical companies based on new sales 2023
R&D, patents, new products
8
- Premium Statistic Total global pharmaceutical R&D spending 2014-2028
- Basic Statistic Global top pharmaceutical companies based on R&D spending 2026
- Premium Statistic Patent expiration risks for total worldwide prescription drug revenue 2020-2028
- Basic Statistic Worldwide prescription drug revenue - market risk from patent expiration 2020-2028
- Premium Statistic Pharmaceutical industry - number of new substances 1998-2021
- Basic Statistic Pharma companies worldwide with active R&D pipelines 2001-2023
- Premium Statistic Number of novel drugs approved annually by CDER 2008-2022
- Basic Statistic Projected most valuable R&D projects based on net present value 2022
Outlook
7
- Premium Statistic World pharmaceutical sales by region forecast 2026
- Premium Statistic Global spending on medicines 2010-2027
- Premium Statistic CAGR by product type in pharmaceutical markets forecast 2023-2027
- Basic Statistic Country comparison in spending on medicine 2026
- Premium Statistic Leading global pharmaceutical products by projected sales 2026
- Basic Statistic Top global biopharma drugs by lifetime sales up to 2026
- Basic Statistic Global top pharmaceutical companies based on R&D spending 2026
Focus: COVID-19 response
7
- Basic Statistic COVID-19 vaccine dose numbers by top manufacturer 2021
- Premium Statistic Top companies by COVID-19 treatment vaccines in development June 2022
- Basic Statistic Number of COVID-19 drugs in development worldwide by phase June 2022
- Premium Statistic BARDA funding for the development of COVID-19 vaccines in the U.S. 2021
- Basic Statistic Forecasted sales of select COVID-19 vaccines worldwide 2021-2022
- Basic Statistic Gilead Science's remdesivir manufacturing projections 2020
- Basic Statistic Global mRNA vaccines and therapeutics market for COVID-19 Q4 2020 vs. 2025
Further related statistics
17
- Total assets of Celgene 2014-2018, by year
- Operating income of Celgene corporation 2014-2018
- Net profit of Roche Farma SA in Spain 2013-2019
- Celgene's expenditure on research and development 2008-2018
- European countries based on public biotech company net income 2021
- Aché Laboratórios EBITDA 2015-2021
- Net income of Bausch Health 2012-2022
- Net income of Regeneron Pharmaceuticals 2016-2022
- Gilead Sciences' net income 2006-2022
- Astellas Pharma's net profit FY 2012-2021
- Genentech: Net income
- Express Scripts' net income 2006-2017
- Qiagen net income 2012-2022
- Net income attributable to IQVIA 2013-2022
- Medco Health Solutions: net income 2006-2011
- Incheon International Airport's net income South Korea 2014-2021
- Taisho Pharmaceutical's net income FY 2013-2020
Further Content: You might find this interesting as well
Statistics
- Total assets of Celgene 2014-2018, by year
- Operating income of Celgene corporation 2014-2018
- Net profit of Roche Farma SA in Spain 2013-2019
- Celgene's expenditure on research and development 2008-2018
- European countries based on public biotech company net income 2021
- Aché Laboratórios EBITDA 2015-2021
- Net income of Bausch Health 2012-2022
- Net income of Regeneron Pharmaceuticals 2016-2022
- Gilead Sciences' net income 2006-2022
- Astellas Pharma's net profit FY 2012-2021
- Genentech: Net income
- Express Scripts' net income 2006-2017
- Qiagen net income 2012-2022
- Net income attributable to IQVIA 2013-2022
- Medco Health Solutions: net income 2006-2011
- Incheon International Airport's net income South Korea 2014-2021
- Taisho Pharmaceutical's net income FY 2013-2020
Celgene Corporation. (February 26, 2019). Net income per share for Celgene from 2014 to 2018 (in U.S. dollars)* [Graph]. In Statista. Retrieved June 02, 2023, from https://www.statista.com/statistics/1039702/net-income-per-share-celgene/
Celgene Corporation. "Net income per share for Celgene from 2014 to 2018 (in U.S. dollars)*." Chart. February 26, 2019. Statista. Accessed June 02, 2023. https://www.statista.com/statistics/1039702/net-income-per-share-celgene/
Celgene Corporation. (2019). Net income per share for Celgene from 2014 to 2018 (in U.S. dollars)*. Statista. Statista Inc.. Accessed: June 02, 2023. https://www.statista.com/statistics/1039702/net-income-per-share-celgene/
Celgene Corporation. "Net Income per Share for Celgene from 2014 to 2018 (in U.S. Dollars)*." Statista, Statista Inc., 26 Feb 2019, https://www.statista.com/statistics/1039702/net-income-per-share-celgene/
Celgene Corporation, Net income per share for Celgene from 2014 to 2018 (in U.S. dollars)* Statista, https://www.statista.com/statistics/1039702/net-income-per-share-celgene/ (last visited June 02, 2023)
Net income per share for Celgene from 2014 to 2018 (in U.S. dollars)* [Graph], Celgene Corporation, February 26, 2019. [Online]. Available: https://www.statista.com/statistics/1039702/net-income-per-share-celgene/